Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression - PubMed (original) (raw)
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression
W D Lo et al. Hum Gene Ther. 1999.
Abstract
Adeno-associated virus (AAV) is a promising vector for central nervous system (CNS) gene transfer, but a number of issues must be addressed if AAV is to be used for widespread delivery throughout the CNS. Our aim was to test the effect of dose, route of delivery, and hydroxyurea treatment on brain expression of beta-galactosidase activity after cerebral inoculation with an rAAV-lacZ vector (rAAV-beta-gal). We also wished to test whether an immune response appeared against the vector and the transgene product. We found in BALB/c mice that beta-Gal expression increased during the first 2 months after inoculation, then decreased slightly by 4 months, and continued out to 6, 12, and 15 months in single animals. Cerebral injection produced localized beta-Gal expression that did not diffuse to other regions despite a fivefold increase in injection volume. Intraventricular injection resulted in negligible transduction. Antibodies to AAV capsid protein and beta-Gal appeared at low levels at 2 and 4 months, but correlated poorly with beta-Gal expression and did not prevent readministration of rAAV-beta-gal. Hydroxyurea treatment did not result in increased transduction in vivo. We conclude that our study confirms rAAV vectors as having considerable potential for CNS gene transfer; however, several important problems must be addressed if this vector system is to be used for long-term transduction of the entire brain. Sustained, regulatable expression will be needed if rAAV is to be used in the treatment of chronic CNS disease. The difficulty in delivering AAV to diverse regions of the brain is an important problem that must be overcome if these vectors are to be used for anything beyond localized transduction.
Similar articles
- Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR, Sferra TJ, Lo W, Qu G, Chen R, Johnson PR. Clark KR, et al. J Drug Target. 1999 Dec;7(4):269-83. doi: 10.3109/10611869909085510. J Drug Target. 1999. PMID: 10682906 - Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC, Zhou S, Bland MP, Escobedo JA, Dwarki V. Manning WC, et al. Hum Gene Ther. 1998 Mar 1;9(4):477-85. doi: 10.1089/hum.1998.9.4-477. Hum Gene Ther. 1998. PMID: 9525309 - Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice.
Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK, Danos O. Snyder RO, et al. Hum Gene Ther. 1997 Nov 1;8(16):1891-900. doi: 10.1089/hum.1997.8.16-1891. Hum Gene Ther. 1997. PMID: 9382955 - Recombinant AAV-mediated gene delivery to the central nervous system.
Tenenbaum L, Chtarto A, Lehtonen E, Velu T, Brotchi J, Levivier M. Tenenbaum L, et al. J Gene Med. 2004 Feb;6 Suppl 1:S212-22. doi: 10.1002/jgm.506. J Gene Med. 2004. PMID: 14978764 Review. - Gene transfer by adeno-associated virus vectors into the central nervous system.
Xiao X, Li J, McCown TJ, Samulski RJ. Xiao X, et al. Exp Neurol. 1997 Mar;144(1):113-24. doi: 10.1006/exnr.1996.6396. Exp Neurol. 1997. PMID: 9126160 Review.
Cited by
- Molecular characterization of adeno-associated viruses infecting children.
Chen CL, Jensen RL, Schnepp BC, Connell MJ, Shell R, Sferra TJ, Bartlett JS, Clark KR, Johnson PR. Chen CL, et al. J Virol. 2005 Dec;79(23):14781-92. doi: 10.1128/JVI.79.23.14781-14792.2005. J Virol. 2005. PMID: 16282478 Free PMC article. - Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitro.
Howard DB, Powers K, Wang Y, Harvey BK. Howard DB, et al. Virology. 2008 Mar 1;372(1):24-34. doi: 10.1016/j.virol.2007.10.007. Epub 2007 Nov 26. Virology. 2008. PMID: 18035387 Free PMC article. - Self-Complementary Adeno-Associated Virus Vectors Improve Transduction Efficiency of Corneal Endothelial Cells.
Gruenert AK, Czugala M, Mueller C, Schmeer M, Schleef M, Kruse FE, Fuchsluger TA. Gruenert AK, et al. PLoS One. 2016 Mar 29;11(3):e0152589. doi: 10.1371/journal.pone.0152589. eCollection 2016. PLoS One. 2016. PMID: 27023329 Free PMC article. - Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.
Merkel SF, Andrews AM, Lutton EM, Mu D, Hudry E, Hyman BT, Maguire CA, Ramirez SH. Merkel SF, et al. J Neurochem. 2017 Jan;140(2):216-230. doi: 10.1111/jnc.13861. Epub 2016 Dec 15. J Neurochem. 2017. PMID: 27718541 Free PMC article. - Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation.
Haery L, Deverman BE, Matho KS, Cetin A, Woodard K, Cepko C, Guerin KI, Rego MA, Ersing I, Bachle SM, Kamens J, Fan M. Haery L, et al. Front Neuroanat. 2019 Nov 26;13:93. doi: 10.3389/fnana.2019.00093. eCollection 2019. Front Neuroanat. 2019. PMID: 31849618 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources